Positrigo key facts
as of Oct 2026- Developer of brain positron emission tomography systems intended to make functional imaging accessible and available for patients.
- Positrigo is valued at approximately $25.9M as of Oct 2026 (last reported valuation).
- It has raised $26.3M; the latest was Later Stage VC ($10.0M) in Oct 2025.
- Notable investors include European Innovation Council, Venture Kick, European Commission, Innosuisse, Zürcher Kantonalbank — 16 tracked in total.
- Status: Privately Held (backing).
Positrigo's last reported valuation, Oct 2025. Nothing priced has surfaced since.
- ·The complete investor list: 16 names
- ·Watch Positrigo: the Monday email on marks, rounds and moves
Positrigo funding rounds
No funding rounds for Positrigo are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
Who backs Positrigo
16+Positrigo valuation
Positrigo's last reported valuation was $25.9 million in Oct 2025. No priced round, secondary trade or fund mark has surfaced since.
Positrigo investors
16 investors are on record for Positrigo, including European Innovation Council, Venture Kick, European Commission and Innosuisse.
About Positrigo
Developer of brain positron emission tomography systems intended to make functional imaging accessible and available for patients. The company offers a brain scanner for diagnostics, treatment monitoring, and the development of new therapies that help in treating specific medical conditions such as Lewy body dementia, Alzheimer's, vascular dementia, and frontotemporal dementia, enabling doctors to diagnose neurodegenerative diseases early in an affordable way.
- Sector
- Healthcare
- HQ
- Zurich, Switzerland
- Founded
- 2018
- Employees
- 23
- Website
- positrigo.com/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.